Prostate Cancer - Results from #21800

Secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: A prospective pilot phase II study - Abstract November 23, 2013

Pathological upgrading and upstaging of patients eligible for active surveillance according to currently used protocols - Abstract November 23, 2013

Patterns in immunohistochemical usage in extended core prostate biopsies: Comparisons among genitourinary pathologists and nongenitourinary pathologists - Abstract November 23, 2013

Optimizing prostate cancer screening; prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program - Abstract November 23, 2013

Potential interest of developing an integrated boost dose escalation for stereotactic irradiation of primary prostate cancer - Abstract November 23, 2013

Relationship between vegetable and carotene intake and risk of prostate cancer: The JACC study - Abstract November 23, 2013

The effects of multidisciplinary rehabilitation: RePCa-a randomised study among primary prostate cancer patients - Abstract November 22, 2013

Factors that predict the development of bone metastases due to prostate cancer: Recommendations for follow-up and therapeutic options - Abstract November 22, 2013

New therapy concepts for castration-resistant prostate cancer : Between hormone manipulation, targeted therapy and chemotherapy - Abstract November 22, 2013

Capsular incision in normal prostatic tissue during robot-assisted radical prostatectomy: A new concept or a waste of time? - Abstract November 22, 2013

Doppler spectral waveform parameters at neurovascular bundle vessels in patients with prostate biopsy - Abstract November 22, 2013

Patterns of practice in the prescription of palliative radiotherapy for the treatment of bone metastases at the Rapid Response Radiotherapy Program between 2005 and 2012 - Abstract November 22, 2013

Budgetary impact on a U.S. Health plan adopting abiraterone acetate plus prednisone for the treatment of patients with metastatic castration-resistant prostate cancer - Abstract November 22, 2013

Inhibition of RANK Ligand to treat bone metastases - Abstract November 22, 2013

Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease - Abstract November 22, 2013

Translational molecular imaging of prostate cancer - Abstract November 22, 2013

Survivorship after prostate cancer treatment: Spouses' quality of life at 36 months - Abstract November 22, 2013

Future prospects in the diagnosis and management of localized prostate cancer - Abstract November 22, 2013

The role of magnetic resonance imaging in the diagnosis and management of prostate cancer - Abstract November 22, 2013

Oral drug may improve survival in men with metastatic prostate cancer November 22, 2013

Page 1091 of 1437